Gene · 5396
Papers1,667
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,667
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of focal adhesion proteins in skeleton and diseases. | Acta Pharm Sin B | 2023 | 36970189 | PubTator, text mining | PubMed |
| Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients. | Mol Ther Nucleic Acids | 2023 | 36969552 | PubTator, text mining | PubMed |
| MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335-5p signaling pathway. | J Orthop Translat | 2023 | 36969134 | PubTator, text mining | PubMed |
| A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases. | Cancer Res Commun | 2023 | 36968142 | PubTator, text mining | PubMed |
| Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single-Cell Resolution. | Adv Sci (Weinh) | 2023 | 36965031 | PubTator, text mining | PubMed |
| Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors. | Commun Biol | 2023 | 36964318 | PubTator, text mining | PubMed |
| Combating pancreatic cancer with ovarian cancer cells. | Aging (Albany NY) | 2023 | 36961421 | PubTator, text mining | PubMed |
| Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies. | Cancer Res Treat | 2023 | 36960624 | PubTator, text mining | PubMed |
| The role of PRX1-expressing cells in periodontal regeneration and wound healing. | Front Physiol | 2023 | 36960156 | PubTator, text mining | PubMed |
| Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. | Front Genet | 2023 | 36959829 | PubTator, text mining | PubMed |
| Epigenetic control of mesenchymal stem cells orchestrates bone regeneration. | Front Endocrinol (Lausanne) | 2023 | 36950693 | PubTator, text mining | PubMed |
| Targeting autophagy process in center nervous trauma. | Front Neurosci | 2023 | 36950126 | PubTator, text mining | PubMed |
| Mesenchymal "stem" cells, or facilitators for the development of regenerative macrophages? Pericytes at the interface of wound healing. | Front Cell Dev Biol | 2023 | 36936686 | PubTator, text mining | PubMed |
| Differential regulation of skeletal stem/progenitor cells in distinct skeletal compartments. | Front Physiol | 2023 | 36926193 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application. | Front Oncol | 2023 | 36895477 | PubTator, text mining | PubMed |
| FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways. | Dis Model Mech | 2023 | 36867021 | PubTator, text mining | PubMed |
| Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane. | Asian Pac J Cancer Prev | 2023 | 36853284 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma. | Front Pharmacol | 2023 | 36843929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5396/papers?page=15